LA JOLLA PHARMACEUTICAL CO short interest in 2021
In 2021, LA JOLLA PHARMACEUTICAL CO's disclosed short interest ran from 11.46% of shares outstanding on 15 Jan 2021 to 2.48% on 31 Dec 2021, a change of -8.98 percentage points. The year's high was 11.46% on 15 Jan 2021 and its low 1.02% on 15 Nov 2021, averaging 6.72% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.88 days on 15 Apr 2021. Full history: LA JOLLA PHARMACEUTICAL CO.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2021 in figures
- Start of year
- 11.46% (15 Jan 2021)
- End of year
- 2.48% (31 Dec 2021)
- Change
- -8.98 pp
- High
- 11.46% (15 Jan 2021)
- Low
- 1.02% (15 Nov 2021)
- Average
- 6.72%
- Highest days to cover
- 17.88 (15 Apr 2021)
- SEC filings marked
- 4
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 11.46% | 1.00 | |
| 29 Jan 2021 | 9.73% | 4.94 | |
| 12 Feb 2021 | 8.74% | 5.07 | |
| 26 Feb 2021 | 9.36% | 8.88 | |
| 15 Mar 2021 | 10.89% | 10.70 | 10-K filed |
| 31 Mar 2021 | 10.92% | 13.55 | |
| 15 Apr 2021 | 11.13% | 17.88 | |
| 30 Apr 2021 | 9.23% | 14.95 | |
| 14 May 2021 | 8.51% | 12.14 | 10-Q filed |
| 28 May 2021 | 8.90% | 8.81 | |
| 15 Jun 2021 | 8.54% | 7.39 | |
| 30 Jun 2021 | 6.57% | 3.99 | |
| 15 Jul 2021 | 6.29% | 10.17 | |
| 30 Jul 2021 | 6.13% | 16.89 | |
| 13 Aug 2021 | 5.69% | 8.81 | 10-Q filed |
| 31 Aug 2021 | 5.06% | 13.33 | |
| 15 Sep 2021 | 5.15% | 16.43 | |
| 30 Sep 2021 | 5.07% | 14.58 | |
| 29 Oct 2021 | 1.09% | 4.07 | |
| 15 Nov 2021 | 1.02% | 3.76 | 10-Q filed |
| 30 Nov 2021 | 1.05% | 1.38 | |
| 15 Dec 2021 | 1.55% | 2.20 | |
| 31 Dec 2021 | 2.48% | 6.37 |
See also: LA JOLLA PHARMACEUTICAL CO's full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.